Advanced Filter

Filter by Group

Filter by Market Availability

Displaying 1 drug
Ertugliflozin belongs to the class of potent and selective inhibitors of the sodium-dependent glucose cotransporters (SGLT), more specifically the type 2 which is responsible for about 90% of the glucose reabsorption from glomerulus. This drug was developed under the collaboration of Merck and Pfizer. It was FDA approved as monotherapy...
Approved
Investigational
Matched Synonyms: … Ertugliflozin
Matched Name: … Ertugliflozin
Matched Description: … Ertugliflozin belongs to the class of potent and selective inhibitors of the sodium-dependent glucose ... It was FDA approved as monotherapy and in combination with sitagliptin or metformin hydrochloride on ... [A31581] This drug was developed under the collaboration of Merck and Pfizer. …
Matched Mixtures name: … Steglujan (Ertugliflozin 5mg/Sitagliptin 100mg) Film-Coated Tablets ... Steglujan (Ertugliflozin 15mg/Sitagliptin 100mg) Film-Coated Tablets ... Segluromet (Ertugliflozin 2.5mg/ Metformin 500mg) Film-Coated Tablet …
Matched Salts name: … Ertugliflozin pidolate
Matched Categories: … sitagliptin and ertugliflozin ... metformin and ertugliflozin ... ertugliflozin ... Alimentary Tract and Metabolism …
Displaying 1 drug